BACKGROUND: ␣6␤1 integrin has been proposed to act as a sperm receptor on the mouse oocyte by interacting with spermatozoon fertilin ␤. We investigated, in humans, whether oocyte integrins could act similarly in gamete fusion, using a cyclic peptide containing the putative disintegrin-binding domain of human fertilin ␤ [cyclic FEE (cFEE)] and RGD peptide. METHODS: Zona-free eggs were inseminated in the absence or presence of peptides. To maintain the membrane protein pattern, the zona pellucida was removed by microdissection. Immunofluorescence and confocal microscopy were used to detect integrin subunits on the oocyte. RESULTS: Unexpectedly, cFEE alone increased human gamete fusion by 94% instead of inhibiting fertilization. Furthermore, cFEE together with RGD potentiated the RGD-induced inhibition of fertilization in a dose-dependent manner. The data suggested the hypothesis of integrin cross-talk, further supported by the co-localization of ␣6␤1 and ␣v␤3 integrins, the putative receptors of cFEE and RGD peptides, respectively. CONCLUSIONS: RGD-sensitive and -insensitive integrins may be associated in a multimolecular complex working as a sperm receptor on the human oocyte membrane. Supplementation of human IVF culture medium with cFEE peptide might improve fertilization rates in ART.
Introduction
The fusion process in all mammalian gametes is mediated by a series of molecular interactions in which members of the tetraspanin, integrin and ADAM (A Disintegrin And Metalloprotease) families have been suggested to play a role (Wassarman et al., 2001; Primakoff and Myles, 2002) . The role of CD9 tetraspanin is now clearly established since homozygous null females exhibit severely reduced fertility (Le Naour et al., 2000; Miyado et al., 2000) . In contrast, the role of oolemma integrins is still debatable (Miller et al., 2000; He et al., 2003) .
Integrins constitute a large family of heterodimeric transmembrane receptors composed of covalently linked α and β subunits. The major function of these cell surface molecules is to mediate cell-cell and cell-extracellular matrix attachment (for a review see Bowen and Hunt, 2000) . Integrin activation induces a conformational change of their outer α and β domains, inducing binding with ligands . Ligand binding induces, in turn, integrin clustering at the cell surface, and recruitment of actin filaments and signalling proteins to the cytoplasmic domain of integrins (Giancotti and Ruoslahti, 1999; Hynes, 2002) . Conversely, intracellular signals can induce integrins to bind to their matrix ligands (Liddington and Ginsberg, 2002) . Eighteen α and eight β subunits have been identified and form 23 known heterodimers (Zhu and Evans, 2002) . Among the integrins, some mediate preferentially adhesion to ligands such as fibronectin, vitronectin and fibrinogen by binding to the RGD motif present in the molecule. They are known as 'RGD-sensitive'. The RGD motif has also been found in snake venom proteins that specifically inhibit integrin binding function and serve as potent integrin antagonists. The majority of these proteins interact with β1-and β3-associated integrins and their potency is at least 500-2000 times higher than that of short RGD peptides (Lu et al., 2003) .
In reproductive biology, there is strong evidence that integrins and their ligands are important mediators of sperm-egg binding. Both spermatozoa and oocytes express a number of integrins and molecules that contain integrin recognition sites. The mouse oocyte contains integrin subunits α2, α3, α5, α6, αv, β1, β3 and β5 as detected by mRNA and/or protein analysis (Tarone et al., 1993; Evans et al., 1995b; Zuccotti et al., 1998; Burns et al., 2002) . Similarly, human oocytes express integrin subunits α2, α3, α5, α6, αv, αM, β1, β2, β3, β4, β5 and β6 (Campbell et al., 1995; Ji et al. 1998; Sengoku et al., 2004) . Among the many different integrin subunits expressed on oocytes, a large amount of data clarifies the major role of α6β1 integrin in the process of gamete binding and/or fusion (Almeida et al., 1995; Takahashi et al., 2000) though it is called into question by others (Evans et al., 1997b; Evans, 1999; Miller et al., 2000) . However, a kinetic experiment revealed that, at an early stage of sperm-egg fusion, the integrin α6 subunits accumulate at the sperm-binding site. The frequency of cluster formation is closely related to that of sperm-egg fusion. This led Takahashi et al. to suggest that sperm-egg fusion actually occurs at sites where the α6β1 integrin is clustered and that this interaction occurs via direct association of integrin α6 with sperm .
Besides oocyte integrins, their putative ligands on sperm, i.e. ADAMs such as fertilin β (ADAM2) and cyritestin (ADAM3), have also been well studied as candidate genes responsible for the sperm-oocyte interaction. Fertilin is an αβ heterodimer first described on guinea pig spermatozoa as the putative ligand by which the sperm interacts with the oocyte (Primakoff et al., 1987) . Fertilin α and β subunits are the prototypes of the ADAM gene family, which are a widely distributed family of evolutionarily conserved transmembrane proteins (Blobel, 1992; Wolfsberg, 1995 Wolfsberg, , 1996 . The disintegrin domain of ADAMs consists of 60-90 amino acids and is homologous to snake venom disintegrins. The snake disintegrin domains contain RGD sequences and competitively inhibit integrin-mediated adhesion of platelets to RGD sequences in fibrinogen and other ligands (Gould et al., 1990) . Structural analysis has revealed that the RGD sequence is present at the top of an extended loop structure, similar to the location of the RGD sequence in fibronectin (Leahy et al., 1996) . However, most ADAMs do not contain an RGD sequence in their disintegrin domain. Indeed, the putative disintegrin tripeptide-binding site of fertilin presents species specificity. In the position of the RGD tripeptide, the consensus sequence in fertilin β (based on cDNA clones) is QDE in the mouse and FEE in the human (Gupta et al., 1996 ; for a review see Evans, 2002) .
In addition to the data obtained in vitro, knockout mice for these genes provided evidence for the participation of the ADAMs in the sperm-oocyte interaction. Thus, fertilin β -/-sperm show greatly reduced levels of binding to the oolemma, but the few that do bind are still able to fuse (Cho et al., 1998) . Moreover, some experiments suggest that integrin α6β1 mediates the binding of fertilin β and cyritestin Yuan et al., 1999; Takahashi et al., 2001; Tomczuk et al., 2003) . Indeed, in the mouse, based on the capacity of specific monoclonal antibodies (mAbs) to inhibit fertilin β binding to the oocyte and the direct binding to this integrin of fertilin β peptides, integrin α6β1 has been suggested to be a receptor for fertilin β (Chen and Sampson, 1999; Bigler et al., 2000) .
On the other hand, members of the RGD-binding integrin subfamily (including αvβ1, αvβ3 and αvβ5) are expressed by oocytes and are implicated in fertilization by studies using RGD peptides in IVF assays (Bronson and Fusi, 1990; Ji et al., 1998) and other work (Linfor and Berger, 2000) . Bronson and Fusi (1990) demonstrated that RGD-dependent recognition is involved in sperm-oolemmal adhesion since RGD peptides inhibit the fertilization rate in the zona-free hamster egg penetration test. Furthermore, the oligopeptide GdRGDSP, specifically designed to block both fibronectin and vitronectin receptors, significantly inhibits the binding of human sperm to the oolemma of zona pellucida-free hamster oocytes (Fusi et al., 1996) . This is of importance since fibronectin and vitronectin are two glycoproteins that contain functional RGD sequences and are both present on human spermatozoa (Fusi et al., 1992 (Fusi et al., , 1994 . Integrins that recognize these ligands have been detected on spermatozoa and eggs. We similarly reported a dose-dependent and partial inhibition of the human gamete fusion by RGD peptide (Ji et al., 1998) . These results indicate that an RGDsensitive integrin is involved in the fusion process. Biochemical analyses have implicated the αv integrin subunit on the pig oocyte in the recognition of isolated pig sperm membrane proteins (Linfor and Berger, 2000) , but direct involvement of RGD-sensitive integrins should be confirmed.
Despite this supportive evidence, a precise role for ADAMs and integrins, RGD sensitive or not, remains to be determined. Moreover, these data will also be discussed with regard to experiments showing that (i) antibody inhibition studies using different conditions did not find inhibition of sperm-egg fusion by an anti-α6 mAb (GoH3) (Evans et al., 1997b; Evans, 1999; Miller et al., 2000) ; (ii) oocytes from α6 knockout mice showed normal binding and fusibility with sperm (Miller et al., 2000) ; and (iii) using β1 conditionally deficient females, α3 integrin null mice and anti-β3 or αv integrin function-blocking antibodies, α3β1 is not essential for sperm-egg binding and fusion and β1 integrin null eggs are fully functional in fertilization both in vivo and in vitro (He et al., 2003) . These results could not totally exclude the possibility of the occurrence of functional redundancy among various integrins and/or of a macromolecular complex including integrins and tetraspanins.
In humans, the fertilization mechanism is rarely studied, mainly because oocytes are rare and precious. Similarly to mouse models, ADAMs and several integrins, including the α6 and β1 subunit, have been suggested to mediate sperm-egg interaction (Fusi et al., 1992; Campbell et al., 1995; Ji et al., 1998) but, once again, these data are called into question by other work (Sengoku et al., 2004) . To address this conundrum, we studied the human gamete interaction process using peptide mimicking the putative binding site of the disintegrin domain of human fertilin β. Effectively, since fertilin α and cyritestin genes are non-functional in human (Jury et al., 1997; Grzmil et al., 2001) , fertilin β appears to be the best candidate for involvement in gamete interaction. As the disintegrin-binding domain of fertilin β is localized at the top of a hairpin loop, we chose to use a cyclic hexapeptide (CSFEEC). Moreover, because the RGD peptide, which inhibits sperm-egg fusion, does not bind to α6β1 integrin, we co-incubated the two peptides. We also propose a model of a membrane receptor in the human gamete fusion process which includes integrins and the CD9 tetraspanin.
Materials and methods

Human gamete preparation
Immature and unfertilized human oocytes were donated by patients undergoing ICSI and IVF, respectively. Exceptionally, a fresh cohort of mature oocytes was given when no spermatozoa were available. Similar results were obtained with these fresh oocytes to those with unfertilized or in vitro matured oocytes for immunostaining and spermegg fusion assay. Informed consent was obtained from all patients and this study was approved by the local ethical committee.
For IVF, normal metaphase II (MII) stage human oocytes were inseminated and examined for the presence of pronuclei 18 h postinsemination. At day 2 post-insemination, oocytes with no signs of fertilization and apparently normal morphology were donated and included in this study.
Following oocyte collection, oocytes intended for ICSI were freed of the surrounding cumulus and corona radiata cells by brief exposure to hyaluronidase (type VIII, 80 IU/ml; Sigma) at 37°C, and gentle pipetting with a Stripper ® micropipettor (135 μm diameter; MidAtlantic Diagnostics, Marlton, USA). They were then scored for the presence of a germinal vesicle (GV) or a polar body. In vitro matured metaphase II oocytes were obtained by incubating GV or metaphase I stage (neither GV nor polar body was present) oocytes under a 5% CO 2 atmosphere at 37°C, in FertiCult™ medium (FertiPro, Beemem, Belgium) for 24 h. Zona pellucida were removed mechanically with a totally chemical and enzymatically free technique, using a pair of microdissection scissors under light Stero-microscope, in order to preserve the integrity of the membrane's protein pattern (Kellom et al., 1992) .
Semen from donors of proven fertility was collected after 3 days of sexual abstinence. Sperm samples were kept at 37°C until liquefaction was completed. A two-step 90/45% PureSperm ® gradient (Nidacon International, Gothenburg, Sweden) was used to select motile spermatozoa (300 g for 20 min). The pellet was washed once with FertiCult™ medium by centrifugation and resuspended to a sperm concentration of 2 × 10 6 /ml for the experiments. Semen analysis was performed according to World Health Organization criteria (World Health Organization, 1999) . The sperm were kept under capacitating conditions for 2 h before insemination (Mortimer et al., 1989) .
Antibodies and peptides
MAb against the human αvβ3 integrin (LM609) and rat mAb against the α6 integrin subunit (GoH3) were purchased from Chemicon International (London, UK). Function blocking mAb against the human β1 integrin subunit (DE9) (Bergelson, 1992) was purchased from UBI (New York, USA). Donkey anti-mouse rhodamine conjugate and a rabbit anti-rat-fluorescein isothiocyanate (FITC) conjugate, mouse adsorbed (Vector Laboratories, Burlingame, CA), were used.
The sequence of the disintegrin domain of human ADAM2 is CLFMSKERMCRPSFEECDLPEYCNGSSASC (accession no. CAA67753). The FEE peptide was synthesized by Neosystem (Strasbourg, France). Its formula, CSFEEC, contained the tripeptide FEE and was cyclized by the adjunction of a cysteine at both ends. The peptide was purified by high-pressure liquid chromatography to >95% purity. The scrambled cyclic peptide CFESEC was obtained in a similar way. For immunofluorescence detection, a biotinylated and cyclized FEE peptide was obtained by adjunction of a biotinylated Gly-Gly chain. RGD-containing peptide (Gly-Arg-Gly-Asp-Thr-Pro) was purchased from Sigma.
Fluorescence staining of human zona-free eggs
Single or double staining were performed by incubating zona-free eggs with primary antibodies for 1 h at the following concentrations: anti-α6 (20 μg/ml), anti-β1 (10 μg/ml) and anti-αvβ3 (10 μg/ml). These incubations were followed by washing with FertiCult™ medium prior to the staining procedure with rabbit anti-rat-FITC conjugate, mouse adsorbed (10 μg/ml), and/or rhodamine-conjugated donkey anti-mouse antibody (20 μg/ml). Eggs were then fixed in 2% paraformaldehyde in phosphate-buffered saline (PBS) at room temperature for 30 min. Oocytes were mounted in Immu-mount antifade solution (Shandon, Pittsburgh, PA), and confocal analysis was performed with a TCS SP2 confocal microscope (Leica, Wetzlar, Germany), using a 63× objective. Negative controls were obtained by substituting the incubation in primary antibody by incubation in PBS-bovine serum albumin (BSA) 1% alone. Non-immune rat immumnoglobulin IgG 2a was also used as control. To verify that clustering was not mediated by the antibodies, labellings were also performed after paraformaldehyde fixation and identical results were obtained.
To detect FEE binding on human eggs, zona-free oocytes were incubated for 1 h with biotinylated cyclic FEE (cFEE; 100 μmol/l). Then, they were incubated with an anti-biotin mAb (Zymed Laboratories, San Francisco, CA), a biotin-conjugated anti-mouse IgG (Chemicon International) and finally with streptavidin-FITC. Detection was performed using confocal microscopy (Bio-Rad MCR1000) on a Nikon Diaphot 300.
Human sperm-egg fusion assay
Due to French bioethical laws, in vitro human gamete fusion assays can only be performed using zona pellucida-free oocytes. Zona pellucida-free mature eggs were pre-incubated with different concentrations of peptides for 30 min in 20 μl FertiCult™ medium drops and then inseminated with 4000 capacitated motile human spermatozoa, in the presence of the same peptides, under mineral oil. Controls were obtained by omitting the peptide or using a scrambled peptide (CFESEC). After 18ˆh, oocytes were washed and loaded with DNA-specific fluorochrome Hoechst 33342 (Sigma) at 5 μg/ml for 20 min. After washing, they were fixed in 4% paraformaldehyde in PBS-BSA 1% for 30 min at room temperature. Eggs were mounted in slides and analysed using a Zeiss Axiophot microscope equipped with a camera and connected to an Imaging System Package (Applied Imaging, Newcastle-upon-Tyne, UK). Spermatozoa were considered as fused when their nucleus became Hoechststained and decondensed.
Statistical analysis
Statistical analysis of the data was determined by Statview ® package. Means were compared by non-parametric Wilcoxon test. Differences were considered significant at P < 0.05.
Results
The ␣6␤1 and ␣ v␤3 integrins are present on human oocyte membrane The immunofluorescence study showed the presence of the α6 and β1 integrin subunits at the surface of the human zona-free egg. They both formed patches ( Figure 1A, B and D) . Merging of the α6 and β1 subunit staining ( Figure 1C) showed a colocalization of both integrin subunits in patches, suggesting the existence of oolemma α6β1 integrin dimers. Patches of αvβ3 integrin were also found at the human zona-free oocyte surface ( Figure 1E ). Merging of α6 and αvβ3 patches showed a colocalization of these molecules ( Figure 1F ). These patches were observed whether fixation was performed after or before labelling and were similar whether labelling was done at 4°C or at room temperature, indicating that they were not induced by the mAb after zona pellucida removal.
Cyclic FEE peptide binds to the human oocyte membrane and increases the number of fused spermatozoa
Immunofluorescence study using the biotinylated cFEE, but not the scrambled peptide, and confocal microscopy showed that it binds to the oolemma of human zona-free oocyte and forms patches (Figure 2A and B) . We therefore decided to perform a sperm-egg fusion assay using the cFEE peptide. According to previously reported experiments in a mouse model (Zhu and Evans, 2002) or in the zona-free hamster oocyte penetration test (Bronson et al., 1999) which showed an inhibition of fertilization with a linear peptide, the same result was expected in a homogeneous human system. Surprisingly, while in control oocytes a mean of 19.0 ± 4.6 (mean ± SD) spermatozoa were found in the cytoplasm (Figure 3A and E) , there was no inhibition of fertilization when gametes were incubated with 100 μmol/l cFEE. On the contrary, we observed an increase in the number of fused spermatozoa per oocyte (36.9 ± 11.7, P < 0.0001) ( Figure 3B and E). Scrambled peptide had no effect on gamete fusion (21.4 ± 4.3, NS) ( Figure 3E ).
Cyclic FEE peptide enhances the RGD-induced inhibition of human gamete fusion
As RGD peptide was known to be an inhibitor of gamete fusion, we tested the co-incubation of both cFEE and RGD peptide in the insemination medium. Co-incubation of 100 μmol/l cFEE and 100 μmol/l RGD peptide accentuated the inhibitory effect of RGD. Indeed, only 4.7 ± 3.9 fused spermatozoa per oocyte ( Figure 3C and E) were observed versus 11.1 ± 3.2 (P < 0.0008) when fertilization occurs with RGD alone (Ji et al., 1998) . Increasing the concentration of RGD to 200 μmol/l induced a dose-dependent decrease in the number of fused spermatozoa with a mean ± SD of 1.7 ± 2.2 (P < 0.0001) ( Figure 3E ). Some of these oocytes presented a complete fusion failure and only the egg metaphase could be seen ( Figure 3D ).
Discussion
The cFEE peptide mimicking the ADAM2 disintegrin-binding domain increases the human oocyte fertilization index. The same effect was obtained in mouse with an equivalent peptide (data not shown). This was a surprise since comparable experiments produced the opposite results in mouse and human. Indeed, recombinant fertilin β and a peptide corresponding to the fertilin β disintegrin loop inhibit sperm oocyte binding and reduce the incidence of fertilization in the mouse (Almeida et al., 1995; Evans et al., 1997b; Bigler et al., 2000; Gupta et al., 2000; Zhu et al., 2000) and in human (Bronson et al., 1999) . Peptides used in mouse studies were either recombinant (Evans et al., 1997b) or synthesized, e.g. CAQDEC (Evans et al., 1995a) or AQD-ECDVT (Zhu et al., 2000) . They all contained the tripeptide QDE and some other adjacent amino acids. The peptide used in the human study was SFEECDLP (Bronson et al., 1999) .
Both the composition and the cyclization of the peptide can explain the absence of an inhibitory effect. It lacked the second aspartic acid of the predicted disintegrin loop pentapeptide sequence QDECD, which has been shown to be critical for its inhibitory properties (Zhu et al., 2000) . Our peptide did not contain this terminal aspartate which seems to be responsible for the inhibitory effect. Furthermore, our peptide was cyclized. It has been shown that restricting the conformational space of active peptide sequences, by using them in cyclic form, could lead to components with improved activity and receptor selectivity. This has been demonstrated for a synthetic cyclic RGDcontaining peptide which was a 20-to 100-fold better inhibitor of cell adhesion to vitronectin and/or laminin fragments when compared with a linear variant (Pierschbacher and Ruoslahti, 1987; Aumailley et al., 1991) . Such hypothesis could explain our peptide's activity. Similarly, linear CAQDEC has been shown to reduce sperm binding and sperm-egg fusion, while the cyclic form did not have any inhibitory effect (Evans et al., 1995a) . This result may, however, be species dependent since Localization by confocal microscopy of integrin subunits α6 and β1, and αvβ3 integrin on zona pellucida-free human oocytes. Zona-free eggs were labelled for integrin subunits α6 (A and D) or β1 (B) or integrin αvβ3 (E) by indirect immunostaining and confocal detection. Images correspond to projections of consecutive optical sections of half oocytes. (C) is the merged image of (A) and (B), and (F) is the merged image of (D) and (E). The co-localization of patches suggests the presence of α6β1 dimers on the human oocyte membrane and its co-localization in a multimolecular receptor with αvβ3 integrin. Figure 2 . Binding of the cyclic FEE peptide to human oocytes. Zona-free human eggs were incubated with biotinylated cFEE peptide. Bound peptide was detected by indirect immunofluorescence. Observation was performed using confocal microscopy. (A) An equatorial section. (B) Superposition of consecutive sections of a half oocyte. The scrambled peptide, CFESEC, did not bind to the egg. Myles et al. (1994) found that an equivalent cyclic peptide was an inhibitor in the guinea pig.
There is, in fact, considerable variation and inconsistency in the literature regarding the efficacy of peptide mimics used in such IVF assays. The technique of oocyte depellucidation may be critical since enzymatic techniques may modify their membrane fertilin receptors (Boldt et al., 1988 (Boldt et al., , 1989 . For example, different zona removal techniques induce different distributions of the α6 integrin subunit (Tarone et al., 1993; Zuccotti et al., 1998; Miller et al., 2000; Takahashi et al., 2000) . To prevent any protease digestion of membrane proteins and eventually of the receptor we are interested in, we performed a totally mechanical zona pellucida removal technique using a pair of microdissection scissors under Stero-microscope without any enzyme or chemical.
As already shown, we found a partial inhibitory effect of RGD peptide on gamete fusion (Ji et al., 1998) . Interestingly, it is potentiated by the cFEE. Hence, in the presence of cFEE, the dose-response effect of RGD achieved an almost complete inhibition for 200 μmol/l. Bronson et al. (1999) described a similar potentiation of the inhibitory effect of RGD peptide by FEE. They used a linear FEE peptide and reported that combined SFEECDLP and G4120, a cyclic RGD-containing peptide, exhibited a strong inhibition of both adhesion and penetration at concentrations that individually had been ineffective, suggesting cooperation between the two receptor ligands during fertilization in human. They suggested that two different integrins should be involved in human gamete interaction, one of which recognizes fertilin and one which recognizes RGD-containing sperm-associated proteins such as vitronectin, and that they may cooperate (Bronson et al., 1999) . Actually, we show that the α6β1 integrin is localized on the surface of human oocyte in patches. Interestingly, RGD-sensitive αvβ3 integrin is also present on the oocyte membrane and co-localizes with the α6β1 integrin, suggesting their direct cooperation within a functional complex ( Figure 1F ). In the mouse, Takahashi et al. (2000) also showed that α6 patches appear on the oocyte membrane at the sperm-binding site prior to fusion. We thus suggest that the functional complex to which the fertilizing sperm binds contains at least these two RGD-sensitive and RGD-independent integrins.
On the other hand, the tetraspanin CD9 is essential for spermegg fusion since female mice that have been deleted for this gene are infertile. Their infertility is related to the inability of the oolemma to fuse with the sperm (Le Naour et al., 2000; Miyado et al., 2000) . Tetraspanins are surface proteins containing four transmembrane domains and forming complexes with each other and with various membrane proteins within a network of molecular interactions called the 'tetraspanin web' (Berditchevski, 2001; Boucheix and Rubinstein, 2001; Hemler, 2003) . They contribute to the formation of cell surface multimolecular complexes and thereby may participate in the functional regulation of molecules with which they associate (Berditchevski, 2001; Boucheix and Rubinstein, 2001; Hemler, 2003) . One hypothesis is that CD9 may be necessary for the patch formation. This could explain the inability of CD9-deleted oocytes to fuse since they are unable to form α6 integrin patches (data not shown).
Finally, the oocyte sperm receptor could be composed of at least two integrins linked by tetraspans, α6β1 and αvβ3, RGDinsensitive and RGD-dependent, respectively. Effectively, both α6β1 and β3 are linked to CD9 in somatic cells. α6β1 integrin is linked to CD9 via CD151 (Serru et al., 1999) and the β3 integrin subunit is associated with CD9 in platelets (Longhurst et al., 1999) . One can therefore speculate that the fusing spermatozoon first binds loosely to α6β1 and induces α6β1 and αvβ3 patch formation. It can then bind tightly to the oocyte through the αvβ3 integrin prior fusion (Figure 4) . Fusi et al. (1996) actually have described the vitronectin receptor as being the possible 'velcro' whereby the sperm binds to the oocyte. αvβ3 is, precisely, the vitronectin receptor (Fusi et al., 1996) . The fact that we detected its presence on the human oocyte surface and its co-localization with the α6β1 integrin supports this hypothesis.
This model allows us to propose the following interpretation of the reported data. When the two peptides are co-incubated, the cFEE peptide induces the recruitment and/or the activation of all available αvβ3 integrin-binding sites on which the RGD peptide binds. Increasing the RGD concentration results in fewer and fewer available binding sites. At 200ˆμmol/l, there Figure 3 . Effects of the cFEE and RGD-containing peptides on the fertilization of zona-free human oocytes. Zona-free human eggs were inseminated with human spermatozoa in the absence (A and E) or in the presence of cFEE peptide at 100 μmol/l (B and E), alone or associated with RGD-containing peptide at 100 μmol/l (C and E) or 200 μmol/l (D and E). Fused spermatozoa were counted under UV excitation. Spermatozoa were considered as fused when their nuclei were Hoechst 33342-stained and decondensed. (E) Means ± SD of different experiments. Numbers above represent the number of human oocytes in each group. *Significantly different from the control (P < 0.0001); **significantly different from RGD alone (P < 0.0008); ***significantly different from FEERGD1000 (P < 0.0001).
are absolutely no free αvβ3-binding sites where the sperm could bind and fuse. This could explain the RGD dose-dependent inhibition of the gamete fusion process in the presence of cFEE. On the contrary, when RGD peptide is incubated alone, it binds to the available αvβ3 integrin. However, one can speculate that the fertilizing spermatozoon can find a free α6β1 integrin site to interact with and induce formation of a complex containing αvβ3 integrin on which the sperm can bind competitively with RGD peptide. This could explain why RGDinduced inhibition of gamete fusion is always partial. When cFEE peptide is incubated alone, it may induce numerous complex binding sites on which the inseminated spermatozoa can bind and fuse easily, explaining the increase in the number of fused sperm. This model also explains how the lack of tetraspanin CD9 in CD9 -/-eggs prevents formation of integrin patches and consequently gamete fusion.
Our findings are in contrast to previous reports stating that integrins are not essential for sperm-egg fusion (He et al., 2003) . However, this assumption is debatable for several reasons. First, there may be several ways in which the oocyte may fuse, some being as yet unknown (Stein et al., 2004) . However, in the physiological process, integrins are effectively present on the oolemma and obviously concerned with the fusion process according to previous reports (Fusi et al., 1992; Almeida et al., 1995; Evans et al., 1997a; Takahashi et al., 2000) . Secondly, the removal of the zona pellucida may bypass a step of the fusion process rendering, for example, the α6β1 integrin useless. This would explain the fusing ability of α6 or β1 integrin genedeleted oocytes. Thirdly, experiments with deleted genes are difficult to interpret. Indeed, studies of knockout mice have shown that frequently there are unanticipated associated defects. Hence sperm from fertilin β and cyristestin knockout mice show reduced binding to the oocyte plasma membrane as expected, but they also adhere poorly to the zona pellucida and show deficient migration from the uterus to the oviduct (Cho et al., 1998) . Analysis of the protein profile of oocytes or sperm of these knockout mice also shows multiple molecular deficiency (Nishimura et al., 2001; He et al., 2003;  for review see Stein et al., 2004) . Finally, redundant molecules may take the place of the deleted protein and assume its functions.
In conclusion, it is the first time that a peptide with the capacity of increasing human gamete fertilizing ability is reported. Such molecule could be used for supplementing the insemination medium to improve the fertilization rate in human IVF and perhaps limit the application of ICSI in assisted reproduction. Despite contradictory data from invalidated gene models, we believe that, physiologically, integrins participate in a multimolecular complex with tetraspanin and probably other as yet undiscovered molecules. 
